Company: ACBM
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001640334-25-001999
Chunk: 3

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 3
---
             Balance, March 31, 2024  -   -   60,042,000   60,042   32,299,396   (32,626,750)  (267,312)                             Imputed interest on related party loans  -   -   -   -   1,057   -   1,057 Net loss  -   -   -   -   -   (10,143)  (10,143)                             Balance, June 30, 2024  -   -   60,042,000   60,042   32,300,453   (32,636,893)  (276,398)                             Imputed interest on related party loans  -   -   -   -   1,123   -   1,123 Net loss  -   -   -   -   -   (10,229)  (10,229)                             Balance, September 30, 2024  -  $-   60,042,000  $60,042  $32,301,576  $(32,647,122) $(285,504)

The accompanying notes are an integral part of these unaudited financial statements.

 6Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Cash Flows

(Unaudited)

   Nine months ended     September 30,    2025  2024        CASH FLOWS FROM OPERATING ACTIVITIES      Net loss $(143,672) $(31,624)Adjustments to reconcile net loss to net cash used in operating activities:        Imputed interest - related parties  6,025   3,134 Changes in operating assets and liabilities:        Security deposit  2,285   - Prepaid expenses  -   1,250 Accounts payable and accrued expenses  (35,563)  1,063 Net cash used in operating activities  (170,925)  (26,177)         CASH FLOWS FROM FINANCING ACTIVITIES